Contract analysis

CLOSING CERTIFICATE OF PENTERRA PHARMACEUTICALS CORP. Delivered pursuant to Section 9.02(a)(iii) of the Master Clinical Trial Agreement dated June 28, 2023 (the "MCTA"), by and between Penterra Pharmaceuticals Corp., a Delaware corporation ("Sponsor" or "Penterra"), and Veridian Health Research Network, Inc., a Delaware 501(c)(3) corporation ("Site Network" or "Veridian") Protocol: PPC-4871-III (CLARION — CLinical As